Evonik silica for Pharmaceutical
Evonik’s silica portfolio supports formulators across solid oral dosage forms, offering proven excipients for powder flow, tablet performance and bioavailability challenges.
As Evonik’s distribution partner, OQEMA connects this portfolio with local expertise, technical dialogue and dependable supply – keeping development projects moving smoothly.



Why silica matters in pharma formulation
Silica excipients play a central role in solid dosage forms, supporting both processability and finished product performance. Depending on grade and morphology, Evonik silicas can:
- Improve powder flow and dosing accuracy
- Enhance tablet hardness and reduce variability
- Support continuous manufacturing concepts
- Increase stability and moisture control
- Improve dissolution of poorly soluble APIs
These functionalities make silica a true multipurpose excipient rather than a simple processing aid
Overview of Pharma-grade silica portfolio
Evonik Pharma-grade silicas are produced in line with IPEC-GMP guidelines and comply with major pharmacopoeia monographs. They are characterised by high chemical purity, low elemental impurity levels and comprehensive quality documentation, supported by auditability and long-standing use as pharmaceutical excipients.
| Product | Primary function | Typical application focus | Key characteristics |
| AEROSIL® 200 Pharma | Glidant | Powder flow and tableting | Industry-standard glidant supporting consistent powder flow, dosing and tablet properties, acting as a central excipient for homogeneous and stable tablets in continuous direct compression |
| AEROSIL® 200 VV Pharma | Glidant | Handling and logistics optimisation | Same functionality as AEROSIL® 200 Pharma with higher density and reduced dust |
| AEROSIL® 300 Pharma | Glidant / performance enhancer | Mechanically stable tablets | Higher surface area supporting enhanced tablet strength |
| AEROSIL® R 972 Pharma | Hydrophobic glidant | Moisture-sensitive formulations | Hydrophobic surface for moisture protection and flow efficiency |
| AEROPERL® 300 Pharma | Carrier Dissolution enhancement | Solubility and bioavailability enhancement | Granulated, mesoporous silica enabling liquid adsorption and dissolution improvement |




